ImmunologybioRxivPreprint
Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)
M. Imbrechts, W. Kerstens, M. Rasulova…·N. Geukens
The paper evaluates a panel of anti-SARS-CoV-2 monoclonal antibodies for neutralizing activity against SARS-CoV-2 delta and omicron variants, finding three mAbs retain activity, with mAb 3B8 showing potent neutralization against both.
DOI 10.1101/2021.12.21.473706